28 research outputs found
Cardiac sarcoidosis and giant cell myocarditis after COVID-19 infection
Get PDFPatients infected with SARS-CoV-2 have varying manifestations of cardiac involvement. We report four patients presenting with symptomatic cardiac sarcoidosis (CS) or giant cell myocarditis (GCM) 1-8 months after mild COVID-19. All patients received immunosuppressive therapy and improved gradually within the following months. The possible temporal association between the CS/GCM and COVID-19 infection might suggest that COVID-19 could be a trigger for granulomatous myocarditis.Peer reviewe
Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by 18F-fluorodeoxyglucose-positron emission tomography: two case reports and a review of the literature
Full text link
Sleep, Sleepiness and Health Complaints in Police Officers: The Effects of a Flexible Shift System
No full textExpert system application for prioritizing preventive actions for shift work: shift expert
No full textGender and working conditions in the European Union
No full textSIGLEAvailable from British Library Document Supply Centre-DSC:OP-EC/4769 / BLDSC - British Library Document Supply CentreGBUnited Kingdo
18F-FDG-PET in Finnish patients with clinical suspicion of cardiac sarcoidosis: Female sex and history of atrioventricular block increase the prevalence of positive PET findings
No full text
